India's specialty chemicals market to grow 10-12% through FY29

India's specialty chemicals market is projected to grow at a 10-12% compound annual growth rate, or CAGR, through FY29 and reach Rs 7,54,100 crore, according to CareEdge Research. The forecast exceeds China's projected growth of about 5% from 2025 to 2029, supported by domestic demand, export potential and supply-chain diversification.

Why is India's specialty chemicals market projected to grow 10-12%?

India's specialty chemicals market is projected to rise from Rs 5,56,300 crore in FY26 to Rs 7,54,100 crore in FY29, producing a 10-12% CAGR over the forecast period. Specialty chemicals are substances made or formulated for specific functions and applications, unlike commodity chemicals that are mass-produced; their performance, quality and customisation are material to end-use applications.

The FY29 projection follows an expansion from Rs 2,24,000 crore in FY19 to Rs 5,56,300 crore in FY26. The historical series represents a 13.9% CAGR through FY26, while the 10-12% projected rate is lower than the historical rate but would add Rs 1,97,800 crore to the market over three fiscal years. CareEdge attributes the outlook to domestic consumption, exports and import substitution in agrochemicals, active pharmaceutical ingredients, or APIs, dyes and polymer additives.

P means projected. The projected growth depends on demand from end-user industries, exports and manufacturers' ability to replace imports in the stated chemical categories. CareEdge also links the FY29 outcome to research and development, backward integration, meaning internal production of inputs, and additions to manufacturing capacity.

How does India's specialty chemicals market compare with Asia?

India's specialty chemicals market is expected to be the fastest-growing major Asian market from 2025 to 2029, at 10-12% annually, compared with about 5% for China. CareEdge places Taiwan at about 6%, South Korea at about 4.5% and Japan at about 3%, making India's projected rate higher than each of those stated comparators.

China's slower projected growth is linked to higher labour costs, environmental regulation and supply-chain shifts. China's average daily wage was USD 9.8-10.0 in 2025, compared with USD 2.27 a day in India. The difference is a stated cost factor, but the report also identifies raw-material availability, infrastructure, compliance and customer approvals as factors affecting manufacturers' ability to compete.

The comparison sits within an Asia-Pacific specialty chemicals market that accounted for 52% of global market value in CY25 and is projected to account for 54% in CY29. The global specialty chemicals market is projected to grow from USD 1,240 billion in CY25 to USD 1,748 billion in CY29 at a 9.0% CAGR, while the Asia-region total is projected to grow at 6-8% over CY25-CY29. India's 10-12% forecast is therefore above both of those projected rates.

What is slowing China's specialty chemicals market?

China's specialty chemicals market is slowing as weak domestic demand, regulations and capacity additions affect producers differently. CareEdge cites a slower-than-expected post-pandemic recovery, weak industrial output and a real-estate downturn that has reduced demand in construction, automotive and electronics-related chemical applications.

China's Dual Control policy, which covers energy consumption and carbon intensity, has increased compliance costs and contributed to shutdowns of high-pollution and non-compliant plants. The report does not describe a uniform contraction because larger environmentally compliant producers have continued to add capacity. That has created overcapacity in certain segments while shifting production towards larger, scale-efficient manufacturers.

Tariffs on Chinese chemical exports and United States efforts to reduce supply-chain dependence on China are additional factors in the report. Multinational companies are using China Plus One strategies, meaning they retain China while adding supply sources elsewhere. India and Southeast Asia are identified as alternative manufacturing locations for companies seeking to diversify supplier exposure.

Which policies and spending plans support India's specialty chemicals market?

India's specialty chemicals market is supported by chemical-sector policies, industrial infrastructure and more than Rs 16,100 crore of planned capital expenditure during FY24-FY26. The planned spending covers capacity expansion, backward integration and product development, including high-value chemicals, fluoropolymers and performance additives.

The report states that 100% foreign direct investment, or FDI, is allowed under the automatic route in chemicals other than hazardous chemicals. It also identifies Petroleum, Chemicals and Petrochemicals Investment Regions, or PCPIRs, as integrated zones intended to offer infrastructure, logistics support and policy incentives. The Bulk Drug Park scheme is designed to reduce dependence on China for APIs and intermediates through common infrastructure including effluent-treatment plants and solvent-recovery units.

A production-linked incentive, or PLI, scheme for chemicals and petrochemicals remains proposed rather than notified, according to the report. Its potential coverage of high-value specialty chemicals is therefore not an existing incentive. Sustaining the FY29 growth forecast requires progress on raw-material security, infrastructure and sustainable manufacturing alongside execution of the disclosed capacity and integration plans.

What could limit India's ability to capture China Plus One demand?

India's specialty chemicals market must overcome customer qualification, compliance and capital requirements before sourcing interest translates into recurring production. Customer registration and approval typically take one to four years and can involve tests of purity, impurities, performance, shelf life and suitability in the relevant end-use application.

Specialty chemical development also requires research and development spending, pilot-scale testing and process optimisation before commercial production. Manufacturing facilities require specialised equipment and may have long gestation periods before commercial viability. The report identifies compliance requirements including Registration, Evaluation, Authorisation and Restriction of Chemicals, or REACH, alongside Environmental Protection Agency, Food and Drug Administration and Bureau of Indian Standards requirements where applicable.

Lower daily labour costs alone will therefore not determine how much production moves to India. CareEdge identifies Gujarat and Maharashtra as established chemical ecosystems, but long-term gains depend on raw-material supply, customer approvals, investment execution and safety and environmental compliance. The more than Rs 16,100 crore planned for FY24-FY26 is relevant because capacity additions must be matched with those operating conditions.

Conclusion

India's specialty chemicals market is projected to grow faster than China and the other major Asian comparators because the FY29 outlook combines domestic demand, export potential, import substitution and China Plus One sourcing. The projected increase from Rs 5,56,300 crore in FY26 to Rs 7,54,100 crore in FY29 contrasts with China's approximately 5% projected growth amid demand, regulatory and capacity pressures.

The next disclosed developments to watch are execution of more than Rs 16,100 crore in planned FY24-FY26 capital expenditure and whether the proposed chemicals and petrochemicals PLI scheme is notified. CareEdge also identifies raw-material security, infrastructure development and sustainable manufacturing as unresolved conditions for maintaining the stated 10-12% growth path.